Machado, Pedro M

Phase II/III Study of Ulviprubart in Inclusion Body Myositis: Study Design, Patient Characteristics, and Topline Results (S7.007)

Goyal, Namita , Machado, Pedro M, Ascherman, Dana P., Benveniste, Olivier, Beydoun, Said R., Brannagan, Thomas H., Christopher-Stine, Lisa, Collins, M P , Dimachkie, Mazen, Dixon, Stacy, Fernández, David , Freimer, Miriam, Geiger, Christopher, González-Pérez, Paloma , Goyal, Neelam, Gwathmey, Kelly, Heitzman, Daragh, Henderson, Robert D., Hodson-Webb, Lisa D., Hussain, Yessar, Korngut, Lawrence, Liang, Christina , Lloyd, Thomas, Naddaf, Elie, Needham, Merrilee, Piccione, Ezequiel, Rosow, Laura, Roy, Bhaskar , Ruck, Tobias, Schmidt, Jens , Seth, Arjun, Shah, Jaimin, Shaibani, Aziz, Shieh, Perry, Simmons, Zachary, Sivakumar, Kumaraswamy, Wang, Leo H. , Weihl, Conrad C., Wilkins, H. Jeffrey, Amato, Anthony, Needham, Merrilee , Machado, Pedro , Machado, Pedro M , Ascherman, Dana P. , Benvéniste, Olivier , Christopher‐Stine, Lisa , Bleecker, Jan De , Dimachkie, Mazen M. , Fernández, David , Goyal, Neelam, Henderson, Robert D. , Hobson‐Webb, Lisa D., Korngut, Lawrence , Lilleker, James B , Lloyd, Thomas E , Mohassel, Payam , Naddaf, Elie , Piccione, Ezequiel, Quinn, Colin , Rosow, Laura K. , Ruck, Tobias , Shieh, Perry B. , Simmons, Zachary , Weihl, Conrad C.

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000215166